SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neuroscience
An SI Board Since June 2000
Posts SubjectMarks Bans
278 22 0
Emcee:  scott_jiminez Type:  Unmoderated
Introduction Compact
The title says it all.

This thread is intended for the discussion of developments in brain research. In the context of SI this implies a debate of approaches by various pharmas and biotechs towards complex neurological pathologies.

Perhaps this sort of forum will result in a distillation of the most exciting investment prospects among the neuro-related biotechs.

I'll try to observe and not 'moderate', leaving the discussion to establish its own course. However, I may be quite aggressive in demanding *objective*, empirical evidence to substantiate company-based claims. My posts on the VD thread (1. Message 13792190 2. siliconinvestor.com provide the framework.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
278Choice cuts? SOURCE: Nature Reviews Drug Discovery signaling-gateway.org Threedr.praveen-1/19/2007
277Use of polysialic acid in repair of the central nervous system Published onlinetnsaf-11/8/2006
276Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Diseanigel bates-8/22/2006
275PR from Prana. 20 July 2006 PBT2 Demonstrates Rapid and Potent Effects in Cognsim1-7/23/2006
274<b>Australian scientists hope new drug will cure Alzheimer's</b>Angelo Ferraro-7/23/2006
273FWIW............ Message 21131945scott_jiminez-3/14/2005
272[Chronic nicotine administration exacerbates tau pathology] >>Published otuck-2/10/2005
271Genentech and Rinat Neuroscience Announce Co-Development and Joint Commercializakeokalani'nui-11/9/2004
270Study Shows Aricept(PFE) Isn't Cost Effective In Treating Alzheimer's AJim Oravetz-6/25/2004
269[Therapeutic immunization protects dopaminergic neurons in a mouse model of Parktuck-6/14/2004
268Published online before print March 16, 2004, 10.1073/pnas.0305755101 April 20,tnsaf-5/24/2004
267Is Alzheimer's Field Blocking Research Into Other Causes? April 9, 2004 SCIEJim Oravetz-4/13/2004
266Jason, thanks for posting that study abstract (I think). Seems to have implicatifred hayes-4/10/2004
265Published online before print March 24, 2004, 10.1073/pnas.0305741101 PNAS | Aptnsaf-4/9/2004
264Published online before print January 2, 2004, 10.1073/pnas.0307453101 PNAS | Jtnsaf-1/14/2004
263CLIOQUINOL IN THE NEWS AGAIN: Clioquinol May Slow Mental Decline in Alzheimer&#Angelo Ferraro-1/3/2004
262<i>From The Scientist</i> November 3, 2003 Preventing prion diseasetnsaf-11/6/2003
261APPROVED: Message 19411505Jim Oravetz-10/17/2003
260Published online before print September 29, 2003 Proc. Natl. Acad. Sci. USA, 10.tnsaf-10/5/2003
259FDA Advisers Evaluate Drug For Late-Stage Alzheimer's Associated Press WASHJim Oravetz-9/24/2003
258Checkup: Alzheimer's Disease By Jennifer Saranow Memantine Forest LaborJim Oravetz-8/27/2003
257Parkinson's patient given GAD gene therapy. Front page article in today'scott_jiminez-8/19/2003
256Myriad Genetics' Alzheimer's Disease Drug Candidate Cuts Production of KJim Oravetz-8/6/2003
255Fascinating. How does it work?scott_jiminez-8/5/2003
254Myriad Genetics comments on Alzheimer's disease candidate drug (MYGN) 14.55:Jim Oravetz-8/5/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News